In our present study, we evaluated two TGF-β1 pathways in gastric cancers by assessing the expression of Smad -dependent and Smad -independent signaling molecules, although we did not compare the expression of TGF-β1 signaling molecules between tumor and normal tissue. This evidence concerns the gene TGFB1 and gastric cancer.